Adam E. Mullick
General / Preventive / Lipids
Ionis Pharmaceuticals (United States)
About
Adam E. Mullick works in General / Preventive / Lipids affiliated with Ionis Pharmaceuticals (United States).
Adam E. Mullick is Vice President of Drug Discovery at Ionis Pharmaceuticals in Carlsbad, California. He previously held research positions at the Scripps Research Institute and has authored publications on lipid metabolism, atherosclerosis, and antisense therapies. His ORCID is 0000-0003-4600-961X.
Research focus
ApoC-III inhibition and triglyceride metabolismAtherosclerosis modulation via Toll-like receptorsCD36 in sterile inflammation and lipid uptakeAntisense oligonucleotide therapies for cardiovascular diseaseRenin-angiotensin system inhibition
Impact
146 pubs · 5,692 cites · h-index 34
Training
PhD
University of California, Davis
2003
Affiliations
Work Experience
Vice President, Drug Discovery
Ionis Pharmaceuticals
Research Associate
Scripps Research Institute